1-(4-Methoxyphenyl)-6-(4-(5-methyl-2-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
98%
- Product Code: 213274
CAS:
1686149-74-5
| Molecular Weight: | 473.52 g./mol | Molecular Formula: | C₂₆H₂₇N₅O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used in pharmaceutical research as a potent and selective inhibitor of phosphodiesterase 10A (PDE10A), this compound is investigated for its potential in treating central nervous system disorders, particularly schizophrenia and other psychiatric conditions involving dysregulated dopamine signaling. It modulates intracellular cAMP and cGMP levels in the brain, especially in the striatum, which plays a key role in motor control and cognition. Due to its ability to cross the blood-brain barrier and exhibit favorable pharmacokinetic properties in preclinical models, it serves as a valuable tool compound for studying PDE10A-related pathways and as a candidate for developing antipsychotic therapies with improved side effect profiles.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿150,000.00 |
+
-
|
1-(4-Methoxyphenyl)-6-(4-(5-methyl-2-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
Used in pharmaceutical research as a potent and selective inhibitor of phosphodiesterase 10A (PDE10A), this compound is investigated for its potential in treating central nervous system disorders, particularly schizophrenia and other psychiatric conditions involving dysregulated dopamine signaling. It modulates intracellular cAMP and cGMP levels in the brain, especially in the striatum, which plays a key role in motor control and cognition. Due to its ability to cross the blood-brain barrier and exhibit favorable pharmacokinetic properties in preclinical models, it serves as a valuable tool compound for studying PDE10A-related pathways and as a candidate for developing antipsychotic therapies with improved side effect profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :